Daily Stock List
Carbon Credits, Inc. (CARN)
Top Stock Tips, OTCBB Journal, OurHotStockPicks, Xtremepicks, First Penny Picks, and PennyStocks24 reported previously on Carbon Credits, Inc. (CARN), and we are highlighting the Company as "One to Watch" here at the QualityStocks Daily Newsletter.
Carbon Credits International, Inc., a leading-edge mobile technology company and full service mobile marketing agency building a family of brands, operates a best-in-class mobile commerce and communication platform. Mobile devices are rapidly changing how organizations interact with individuals, and Carbon Credits International provides state-of-the-art platforms and services that enable clients to successfully leverage the mobile evolution to their advantage.
Carbon Credits recently acquired SinglePoint, a company that works in partnership with entertainment, media companies, brand managers, advertising agencies, and mobile networks to deliver a full suite of mobile products and services. Current publisher partners include NBC Universal (Bravo, Oxygen, SyFy, CNBC, MSNBC, Telemundo, USA Network), ABC/Disney, Viacom and CBS Corp.
SinglePoint once dominated the broadcast media space for mobile messaging and were widely recognized for their high volume message routing platform that was uniquely developed for supporting the mobile industry's high volume SMS campaigns including: Deal or No Deal, Red Cross Haiti campaign, Obama '08 campaign, Beijing & Vancouver Olympics, American Idol, and many others. In addition to gaining this high volume message routing platform, Carbon Credits will has also acquired SinglePoint's SMS campaign management tool, which was used throughout broadcast media for creating and managing mobile campaigns for top brands.
Greg Lambrecht, CEO of Carbon Credits, said the following when the acquisition was announced: “With the purchase of SinglePoint's name and technologies, Carbon Credits International Inc. has instantly enhanced its ability to become a leader in the mobile messaging and mobile payments industries. This acquisition will allow us to support extremely high level text messaging programs without requiring the Company to upgrade its technology and incurring additional expense. I'm confident this will attract more business."
Carbon Credits also has their Text-a-Day and Text-4-Faith brands, which are enabling successful giving campaigns via the mobile phone for non-profit organizations. Charitable giving in the United States approaches $300 billion annually, of which more than 70% is donated by individuals, the vast majority of whom own a mobile device. A third of this market, $100 billion, is channeled to religious entities.
The Text-4-Faith platform provides targeted services allowing ministries to engage members with enhanced communication and enabling their ability to donate via their mobile phone. Similarly Text-a-Day provides these capabilities for any nonprofit organization focused on engaging supporters and driving fundraising. Text-a-Day also enables nonprofits to effectively engage consumers with targeted marketing campaigns that drive transactions through its mobile commerce platform.
We're tracking Carbon Credits, Inc. (CARN) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.
Carbon Credits, Inc. (CARN), closed Thursday's trading session at $0.0098, up 84.91%, on 31,029,411 volume with 472 trades. The average volume for the last 60 days is 1,279,237 and the stock's 52-week low/high is $0.0025/$0.25.
Marathon Patent Group®, Inc. (MARA)
Today we are highlighting Marathon Patent Group®, Inc. (MARA), here at the QualityStocks Daily Newsletter.
Headquartered in Alexandria, Virginia, Marathon Patent Group®, Inc. is an intellectual property (IP) services and monetization enterprise. Marathon serves a broad spectrum of patent holders and technologies from Fortune 500 to independent inventors. The Company serves clients through two complementary business units: the IP Research & Services Center, and the IP Licensing and Enforcement Group. Marathon Patent Group®'s shares trade on the OTC Markets' OTCQB.
The Company provides their clients advice and services that enable them to realize financial and strategic return on their IP rights. Their IP Research & Services Center helps to identify and manage patents. Their IP Licensing and Enforcement Group acquires IP assets, partners with patent holders, and monetizes patent portfolios through actively managed patent licensing campaigns.
Marathon Patent Group® provides their clients proprietary analytics, IP valuation methods, partnering opportunities, infringement tracking, patent analysis, strategies, tactics, enforcement and reporting among others. The Company has a portfolio consisting of 14 patents in the U.S, and 27 International Patents. They acquire patents and patent rights from the owners of the patents. They compensate the patent seller by either providing an upfront payment or by providing the patent seller participation in the revenue generated from the licensing activities, or a combination of both.
Last week, Marathon announced that their wholly owned subsidiary, Relay IP, Inc., acquired US Patent 5,331,637 from MOSAID Technologies. The asset is a seminal patent cited by more than 254 other patents that enables multicasting on Internet protocol networks. MOSAID Technologies is one of the world's leading intellectual property management companies.
Yesterday, Marathon Patent Group® provided an update on their recent acquisition of CyberFone Systems, LLC and their patent portfolio. The patents cover claims that provide the right to practice specific transactional data processing, telecommunications, and network and database inventions, including financial transactions.
Marathon believes these patents cover inventions that are in extensive use, particularly in the mobile internet environment. Marathon and IP Navigation (IPNav), the Company's strategic partner, will continue to identify, and license to, those who market or sell technologies covered by the underlying rights of the acquired assets. This includes infringement in already identified industries, and in newly identified verticals or use cases. IPNav is the world's leading full-service patent monetization firm.
Marathon Patent Group®, Inc. (MARA), closed Thursday's trading session at $0.38, up 2.70%, on 26,600 volume with 10 trades. The average volume for the last 60 days is 16,411 and the stock's 52-week low/high is $0.20/$1.15.
Quantum Materials Corp., Inc. (QTMM)
PennyStocks24, Pumps and Dumps, Winning Penny Stock Picks, WePickPennyStocks, Super Nova Stock Picks, Penny Stock Pick Report, Penny Stock Pick Alert, PennyStockMoneyTrain, Liquid Tycoon, StockMister, PricelessPenny, Bullseyestox.com, AddictivePennyStocks, and PennyStockRumors.net reported this week on Quantum Materials Corp., Inc. (QTMM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Quantum Materials Corp., Inc., together with their wholly owned subsidiary, Solterra Renewable Technologies, Inc., manufactures and commercializes quantum dot technology products. The Company previously went by the name Hague Corp. They changed their name to Quantum Materials Corp., Inc. on April 13, 2010 to reflect their nanotechnology business.
This week, Quantum Materials announced that the Company has chosen the greater Austin area in Texas to relocate headquarters and to establish their R&D labs. They decided that Austin's "Silicon Hills" offers superior business advantages to emerging companies in both the nanotech and biotech fields. Quantum Materials shares trade on the OTC Markets' OTCQB.
Quantum dot semiconductors enable a new level of performance in a broad spectrum of established consumer and industrial products. These include low cost flexible solar cells, low power lighting and displays and biomedical diagnostic applications.
Quantum Materials' Solterra Renewable Technologies is positioned to lead the development of sustainable and cost-effective solar technology. This is through introducing a new dimension of cost reduction by replacing silicon wafer-based solar cells with high-production, low-cost, efficient, flexible thin-film Tetrapod Quantum Dot solar cells.
Last month, Quantum Materials announced that they recently developed and delivered customized tetrapod QD samples for applications undergoing development by Department of Energy National Lab researchers. In addition, the Company has agreed to supply customized tetrapod quantum dots to a U.S. government defense related agency in support of a nano-biological project.
Quantum Materials believes that their technology meets three NNI National Signature Initiatives objectives. These are new advanced materials (tetrapod quantum dots), mass production (continuous flow process) and nanomanufacturing (roll-to-roll printing). Currently, the Company offers high-brightness Cd-based and ecological Cadmium-free non-heavy metal tetrapod QD. They can synthesize several Group II-VI inorganic mono or hybrid tetrapod quantum dots.
Quantum Materials' intention is to build out their quantum dot production facilities in the United States. They expect full commercial production in the fourth quarter of 2013.
Quantum Materials Corp., Inc. (QTMM), closed Thursday's trading session at $0.0735, up 8.09%, on 399,692 volume with 39 trades. The average volume for the last 60 days is 180,629 and the stock's 52-week low/high is $0.04/$0.112.
AccelPath, Inc. (ACLP)
Wallstreetlivechat reported earlier on AccelPath, Inc. (ACLP), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Headquartered in Gaithersburg, Maryland, AccelPath, Inc. is a wholly owned and operating subsidiary of Technest Holdings, Inc. (TCNH). AccelPath provides technology solutions that play a crucial role in delivering information required for diagnosis of diseases and other pathologic conditions with and through their associated institutional pathologists. The Company provides medical diagnostic and government contracting services in the United States.
AccelPath looks for referring physicians and histology laboratories that require high-quality pathology interpretations and manages HIPAA-compliant digital case delivery and reporting while developing all-embracing solutions for managing medical information.
The Company is focusing on the multi-billion dollar anatomic pathology market in the United States. AccelPath's business model builds upon the expertise of experienced pathologists to provide seamless, reliable and comprehensive pathology and special test offerings to referring physicians using conventional and digital technologies. Their Information Technology (IT) and communications platform enables them to deliver diagnostic reports to referring physicians efficiently and securely. Furthermore, AccelPath's IT platform enables close tracking and monitoring of medical statistics.
Parent company Technest Holdings focuses on the design, research, development and integration of three-dimensional imaging devices and systems, principally in the healthcare industries. Additionally, they develop solutions and intelligent surveillance devices and systems, as well as three-dimensional (3-D) facial recognition systems for security and law enforcement agencies. Their solutions take advantage of several core proprietary technology platforms, such as 3D imaging technologies.
Technest's core technology platforms include 3D Imaging Technology Platforms: 3D capture using structured white light, 3D filtering and data manipulation, 3D display in volumetric space. Core platforms also include Intelligent Surveillance Technology Platforms: 360-degree video acquisition using mirror, lens, and array configurations, and 2D & 3D video detection and enhancement algorithms.
In addition, core platforms include 3D Facial Recognition Technology Platforms (3D facial recognition and enhancement algorithms), and General Technology Platforms (small, high-speed sensor processing hardware).
AccelPath, Inc. (ACLP), closed Thursday's trading session at $0.0011, up 10.00%, on 2,000 volume with 1 trade. The average volume for the last 60 days is 3,323,713 and the stock's 52-week low/high is $0.0007/$0.11.
Converge Global, Inc. (CVRG)
Stocktwiter reported recently on Converge Global, Inc. (CVRG), HotStockProfits, Penny Stocks Gone Wild, Penny Stock Peepshow, Mad Money Picks, Stock Shock and Awe, Penny Stock General, Fast Money Alerts did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter
Listed on the OTC Pink Current Information, Converge Global, Inc. is a diverse enterprise headquartered in Toronto, Ontario. The Company is currently developing Majestic Menu, a division that will feature www.majesticmenu.com. This is an online portal and media platform for the hospitality and food service industries. Majestic Menu is to assist in the identification and obtaining of products and services from the local, national as well as global marketplace.
Converge Global will continue to look for potential acquisitions, encourage strategic alliances, and assess business development to support and expand their tiered network and corporate growth. The Company's Majestic Menu is now preparing for their retail test market. They will feature current and progressive media and technological strategies. The site will be a form of online purchasing that can be engaged to enhance or direct traditional retail and commercial distribution.
The expectation is that Majestic Menu will attract an extensive range of retail and commercial alliances, distributors and purchasers. Online buyers will have the opportunity to purchase retail direct from distributors; the commercial accounts will undergo customization correspondingly.
This past January, Converge Global announced that the Company's new division, Majestic Menu, executed a Letter of Understanding to collaborate with Preferred Communications, Inc. to produce "Majestic Menu" as a magazine supplement in print and online with "Preferred Magazine".
Majestic Menu magazine will feature reviews, articles, marketing campaigns and products to be available via their online website. Moreover, Cornelia Volino, President and Chief Executive Officer of Converge Global, will be a contributing writer with Preferred Magazine featuring articles in cuisine, wine/spirits and cigars.
Ms. Volino is a leader in the hospitality and foodservice industry. Her commitment is to provide strong leadership in corporate development, negotiations, acquisitions and the implementation of Majestic Menu, Converge Global's principal division. She combines her industry network with a media portfolio of television, magazine and web expertise in corporate relations, administration and public acquisitions.
Converge Global, Inc. (CVRG), closed Thursday's trading session at $0.052, up 1.96%, on 42,100 volume with 4 trades. The average volume for the last 60 days is 81,741 and the stock's 52-week low/high is $0.008/$0.915.
A.P. Pharma, Inc. (APPA)
Real Pennies, Stock Stars, MonsterStocksPicks, SmallCap Network, PennyStocks24, NYC Marketing Inc, The Street, and TopStockAnalysts reported on A.P. Pharma, Inc. (APPA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
A.P. Pharma, Inc. is a specialty pharmaceutical company with corporate headquarters in Redwood City, California. The Company is developing products using their proprietary Biochronomer™ polymer-based drug delivery platform. The design of this drug delivery platform is to improve the therapeutic profile of injectable pharmaceuticals through converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
The Company's lead product is APF530. It is undergoing development for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). CINV is a leading cause of premature discontinuation of treatment. A.P. Pharma resubmitted their New Drug Application (NDA) for APF530 to the U.S. Food and Drug Administration (FDA) in September 2012. In addition to APF530, the Company has a pipeline of other product candidates that use the Biochronomer™ technology.
APF530 contains the 5-HT3 antagonist granisetron formulated in A.P. Pharma's proprietary Biochronomer™ drug delivery system that allows therapeutic drug levels to be maintained for five days with a single subcutaneous injection. The design of this five-day range is to cover the delayed phase of CINV; currently available intravenous and oral formulations of granisetron are approved only for the prevention of acute-onset CINV. Granisetron was selected for APF530 because physicians, based on a well-established record of safety and efficacy, extensively prescribe it.
In late March, A.P. Pharma announced that they received a Complete Response Letter (CRL) from the FDA regarding their New Drug Application (NDA) for APF530. The CRL describes issues that must be addressed by the Company. With respect to chemistry, manufacturing and controls (CMC), the FDA requested the refinement of one product quality analytical test method, and that certain deficiencies identified during facility pre-approval inspections be addressed.
The FDA also requested that a human factors validation study evaluating the usability of the APF530 syringe system together with its proposed product labeling and instructions for use be conducted with product assembled using a validated, commercial process.
Additionally, pertaining to clinical, the FDA requested a re-analysis of the existing Phase 3 clinical data that reclassifies patients into those receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC) according to the recently modified ASCO 2011 Guideline. The FDA did not request any new clinical studies.
A.P. Pharma, Inc. (APPA), closed Thursday's trading session at $0.33, down 2.94%, on 739,342 volume with 108 trades. The average volume for the last 60 days is 2,559,768 and the stock's 52-week low/high is $0.28/$0.887.
LabStyle Innovations Corp. (DRIO)
PennyStocks24 reported this month on LabStyle Innovations Corp. (DRIO), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2011 as a Delaware corporation, LabStyle Innovations Corp. is the developer of the Dario™ smartphone-based diabetes management system. Dario™ is a stylish, user-friendly device and software system that will compete in the multibillion-dollar market for patient self-monitoring of blood glucose (SMBG) products. LabStyle Innovations has their headquarters in Ramat Gan, Israel. The Company's shares list on the OTC Markets' OTCQB.
LabStyle Innovations has developed and is commercializing a patent-pending technology that looks to bring laboratory testing capabilities to consumers in a unique, easy to use and affordable way using smartphones such as iPhones.
In essence, the Company's Dario™ integrates a pocket-sized glucometer with a mobile app and secure cloud computing. It replaces bulky personal glucometers and unwieldy data collection with an elegant and mobile diabetes management system based on a user's smartphone.
Dario™ is a complete, patent-pending system that combines an all-in-one SMBG device consisting of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge, and a smartphone-driven glucose reader adaptor, coupled with a smartphone application and internet-based data services. Each strip cartridge holds 25 strips. Dario™ effortlessly connects to a user's smartphone headphone socket and automatically synchronizes with their Dario™ application
The expectation is that Dario™ will be available this year, first in Europe and later in North America. This is following receipt of applicable regulatory approvals.
This week, LabStyle Innovations announced that Dr. Oren Fuerst, the Company's Chairman and CEO, will present at the 12th Annual Needham Healthcare Conference on Tuesday, April 30 at 4:20 p.m., Eastern Time. The presentation will provide a corporate overview and a discussion of LabStyle Innovations' growth strategy. The conference will take place at The Westin Grand Central Hotel, 212 East 42nd Street, in New York City from April 30 to May 1, 2013. Dr. Fuerst's presentation will be webcast as well.
LabStyle Innovations Corp. (DRIO), closed Thursday's trading session at $2.77, up 4.53%, on 140,662 volume with 39 trades. The average volume for the last 60 days is 25,171 and the stock's 52-week low/high is $2.00/$3.00.
3D Eye Solutions, Inc. (TDEY)
Pumps and Dumps, Pennybuster, HotShotStocks, PennyDoctor, SmallCapStockPlays, PennyInvest, HotOTC, StockEgg, CoolPennyStocks, PennyStockVille, MadPennyStocks, and BullRally reported previously on 3D Eye Solutions, Inc. (TDEY), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
3D Eye Solutions, Inc. is a service provider, developer, and integrator for the 3D (Three-Dimensional) Stereo and Auto-Stereo media industry. Incorporated in 1992, the Company has expertise in content conversion. Their goal is to develop and produce properties that will heighten the viewer's experience, while making it cost effective for productions and post-production projects to work with an efficient pipeline. All of the Company's conversions undergo processing in their Florida studio. 3D Eye Solutions lists on the OTC Pink Current Information.
3D Eye Solutions has their 3D Reality Splitter™ software. This software allows the Company to produce premier stereo imagery in all formats of 3D. This is from 2D to 3D conversions to Auto-Stereoscopic 3D displays and integrated systems. The Company provides conversion services for the Cinema, Digital Signage and Home Theater markets.
The Company's services consist of taking existing (Film libraries, commercials, advertisements, and more) and new properties with their own proprietary techniques and processing power to create flexibility with depth and forward projection. 3D Eye Solutions is also developing properties and appliances that integrate with 3D Stereo and multi-view products/displays through creating license and distribution channels to monetize properties.
The Company provides two formats to release to, stereo and auto-stereo. With their post-production process, they eliminate all the issues of filming in stereo with a stereo rig on site. The Company's process is in a controlled environment. It does not require a stereo pair (left eye/right eye). They use their reality 3D Reality Splitter™ technology to take an existing film (HD 2K, 4K) and process it for 3D formats, including RealD, Dolby3D, as well as digital 3D outlets.
3D Eye Solutions services also include Stereo and Multi-view consulting and integration; Value Added Reseller (VAR) of turnkey multi-view systems for digital signage; and custom development for integrations (digital signage, cinema, medical, military, mobile, and more).
Services additionally include Digital Signage - large format auto-stereoscopic displays for potential Advertisers. The Company also produces and processes media content for Film, Television, Corporate, Venues and Trade Show Events. Additionally, 3D Eye Solutions provides turnkey systems and converts existing media to enable end users to display properties in a multi view format.
3D Eye Solutions, Inc. (TDEY), closed Thursday's trading session at $0.0003, even for the day, on 31,032,511 volume with 26 trades. The average volume for the last 60 days is 10,683,941 and the stock's 52-week low/high is $0.0002/$0.0086.
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.0907, off by 9.30%, on 43,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 28,440, and its 52-week low/high is $0.073/$0.1721.
VentriPoint Diagnostics Ltd. reported reception today of a short list of suggestions for clarification from the FDA regarding the company's Pulmonary Arterial Hypertension 510(k) review submission, as part of the FDA's Interactive Review Process, designed to facilitate premarket medical device submissions. CEO of VPTDF, Dr. George Adams, was excited to see the FDA come back so quickly with suggestions and assured markets that the company was already working on the small number of requisite modifications to the filing.
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
VentriPoint Receives Request for Clarification to 510 (k) Submission for Pulmonary Arterial Hypertension
VentriPoint Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
VentriPoint Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.134, up 6.35%, on 753,421 volume with 137 trades. The stock’s average daily volume over the past 60 days is 92,081, and its 52-week low/high is $0.0322/$4.88.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
DoMark Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
DoMark International Announces the Signing of an M.O.U. to Purchase Game Changing New Samsung and Apple Accessory Product Developer Zaktek Ltd.
Apple and Samsung Accessory Leader: DoMark Announces the Finalization of Its Restructure
Soul and Vibe Interactive, Inc. (SOUL)
The QualityStocks Daily Newsletter would like to spotlight Soul and Vibe Interactive, Inc. (SOUL). Today, Soul and Vibe Interactive, Inc. closed trading at $0.30, up 1.69%, on 92,000 volume with 19 trades. The stock’s average daily volume over the past 60 days is 137,175, and its 52-week low/high is $0.26/$1.45.
Soul and Vibe Interactive, Inc. (SOUL) is a publisher of games and game-related content for consoles, mobile devices, and personal computers. The company specializes in creating original intellectual properties and has extensive experience licensing world-renowned brands from influential companies. Notably, Soul and Vibe is the only company with the right to license General Mills brands for video game applications.
Leveraging partnerships with software developers around the world, Soul and Vibe transforms unique concepts into engaging and affordable entertainment experiences. The game publisher has established game development and publishing agreements for the Xbox 360® video game and entertainment system, Windows 8, Windows Live, and Windows Phone from Microsoft, and the PlayStation® 3 computer entertainment system and PlayStation® Vita (PS Vita) from Sony.
Soul and Vibe stands out from the crowd by breaking through marketplace clutter and noise via direct-to-consumer tactics that reverberate from the core player to the mainstream gaming audience. Making games as fun to talk about as they are to play is a key focus of the company. The more personable and memorable the play experience, the more likely consumers and press will talk about the game and its publisher.
The burgeoning game industry spans across diverse demographics and offers wide-ranging opportunities for profit and growth. Consumer spending on console, mobile, and personal computer game software exceeded $56 billion in 2010 and is projected to reach $82 billion by 2015. This revenue represents more than 2x the size of the music industry and nearly 3/5th the size of the entire film industry. Disclaimer
Soul and Vibe Interactive, Inc. Company Blog
Soul and Vibe Interactive, Inc. News:
Soul and Vibe to Build Micro-Transactions Into Its Console, Mobile, and PC Games
Soul and Vibe to Pursue Business Development Deals at Game Connection Conference in San Francisco
Soul and Vibe to Monetize Avatars to Create Marketing Impressions and Additional Revenues
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0152, up 0.66%, on 10,650 volume with 3 trades. The stock’s average daily volume over the past 60 days is 799,926, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
VIASPACE Insiders Extend Lock-up of Shares
VentriPoint Diagnostics, creator of the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function, announced that the U.S. Food and Drug Administration (FDA) responded to its Pulmonary Arterial Hypertension (PAH) 510(k) submission with a short list of suggestions, clarifications and requests for additional information.
“We are very pleased the FDA has reviewed our submission so expeditiously and we now have a small number of modifications to the filing to prepare,” said, Dr. George Adams, CEO of VentriPoint.
Known as the most serious form of the five recognized groups of pulmonary hypertension, PAH is a devastating disease with an average patient lifespan of less than 3 years after diagnosis if untreated. The disease affects individuals of all ages, even infants. Although quickly applying treatment helps, most patients with PAH are diagnosed too late for any therapy to be fully effective.
The VMS™ analysis system is currently for investigational use only in the United States and approved for clinical use in Canada and Europe. VentriPoint designed this system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
For more information on VentriPoint and VMS™, visit www.ventripoint.com
The U.S. entertainment industry is aggressive in nature, comprised of market players producing a vast and diverse offering of experiences and simulations that cater to every imaginable consumer demographic. The gaming segment of the industry has achieved exceptional performance throughout its history, and isn’t showing any signs that it will slow its pace.
Consumer spending on console, mobile, and computer games exceeded $56 billion in 2010 and experts forecast it will hike to $82 billion by 2015. This growth trend is nothing new – America’s entertainment industry, especially the gaming market, has historically demonstrated its progressive value.
From 2005-2009, as the U.S. economy grew at a rate of less than 2 percent, the entertainment software industry’s annual growth rate topped 10 percent, according to Video Games in the 21st Century: The 2010 Report. For the same four-year period, direct employment for the industry grew 8.5 percent annually.
Competing and creating a recognizable brand in a rapidly burgeoning industry requires strong leadership that is familiar with navigating the waters. For more than 22 years, award-winning industry veteran Peter “Tony” Anthony Chiodo has piloted himself through nearly every aspect of the video and computer games industry.
Chiodo has extensive experience leading and managing software production teams, studio professionals, and entire production departments, and has directed more than 30 externally contracted development teams based all over the world. His creative efforts also resulted in the release of more than 100 frontline and “casual” games within a four-year span.
He has also produced serious games training tools for the U.S. Marine Corps and the Defense Advanced Research Projects Agency, as well as consulted software companies in the healthcare industry to produce simulations to assist in advanced patient care.
Chiodo is also the founder and CEO of innovative video and computer games company, Soul and Vibe Interactive. The company is focused on building original intellectual properties (IPs), partnering with leading software developers around the world to turn unique concepts into affordable games and entertainment options.
Leveraging his standing relationships with independent software developers, licensing agents, professional athletes, and toy companies, Chiodo has created a business model that thrives on established licensing deals with third-party merchandising companies. Soul and Vibe is one of only about 60 companies in the world licensed by Microsoft to publish content on Xbox 360. Soul and Vibe is also licensed by Sony to publish content on PlayStation 3 and PlayStation Vita.
Taking advantage of strong consumer trends and a solid management profile, Soul and Vibe believes it is positioned to reach profitability by 2014 and achieve $35 million in revenues by 2015, supporting its mission is to become a significant player in the video and computer games industry.
For more information visit www.soulandvibe.com
Santo Mining, who is doing some superb work in the Dominican Republic, reported news today out of their Charles Claim, as geochemical analysis of rock sampling comes back with 10.79 g/t silver and over 1% copper.
These are solid reads from the silver-copper rich host formation known as the Tireo and the results accentuate the prime geographical position of this claim nicely, lying as it does, smack next to Goldquest’s La Escandalosa claim (trenching results like 8.71 g/t gold over 91.8 feet). Work done a decade ago by Goldquest and Goldfields in the region led to kicking up their five-site, 22-mile long swathe of areas of heavy gold and copper mineralization (Romero, La Escandalosa and etc.), with the most recent work done in 2012 at La Escandalosa showing several bonanza grade intercepts as high as 847 feet grading 7.88 g/t Au and 1.43% Cu.
In this regional geologic context, especially considering the undeveloped nature of the lands, the rock sampling done by SANP looks cherry. Sample processing was handled by well-known Vancouver-based industry benchmarking firm, Acme Labs, who performed multi-element and fire-assay analysis. With these kinds of fresh reconnaissance survey results in hand, from just northeast of what is the biggest gold discovery in the Dominican Republic in two decades, shareholders at SANP are no doubt beaming with pride.
This comprehensive surveying effort of the 687-acre Charles site was begun back in March by the company’s ingeniously designed mobile strike team, headed up by Elpidio Moronta. The effort managed to capture quite a high-res portrait of the site’s mineral potential. Stream sediment sampling of the Rio Guayabo and Rio Piedra Blanca rivers/tributaries, combined with grab and outcrop samples, including ones from several key areas of the Rio Piedra Blanca river, have yielded a clear picture, with even the lower end of the spectrum offering quality grades.
President of SANP, Al French, told markets that the exploration team is already headed back out the door to Charles to do some more detailed sampling in the prospective zones identified by these survey results. French also explained that management was putting in some really late nights back at the company’s Santo Domingo offices, in order to quickly secure as many as four more claims clustered in the target area. These new claims are all around Goldquest’s bonanza claims and French indicated that SANP was looking at applying the recent (Mar 12) $16M commitment (an equity enhancement program designed to spur SANP’s aggressive exploration plans) from New York-based Magna Group affiliate, Hanover Holdings I, LLC, to development of the Charles.
For more information on Santo Mining, visit www.SantoMining.com
Sibling Group Holdings, a company focused on enhancing and accelerating the delivery of 21st century learning, today announced its plan to open an operation in Atlanta to provide teacher certifications in a number of key areas. The initial focus will be on the teacher requirements for the Pre-K market, where a rising number of states are mandating a range of certifications from teachers.
“We see the need for certification and credentialing services growing as the education industry transforms from traditional school systems to reflect more independent, private, charter and corporate education oriented entities,” stated Neal Sessions, Chairman of Sibling. He continued, “While we will begin in Atlanta with the Pre-K requirements, we expect certification programs to grow to include other geographic regions and specialties such as ESL/ELL and certain STEM course areas.”
Most states have a number of options for pre-K teacher requirements. These options may include a stated number of hours in post-secondary education in child development or early childhood education, a Child Development Associate (CDA) certification, or a diploma as a child development technician. There are several teacher certifications that some states list as acceptable for part or all of the teacher requirements in licensed daycare facilities. Sibling Group will pursue fully accreditation through the International Association for Continuing Education and Training (IACET), and other accreditation organizations, as it expands its course offerings.
The national certification for Pre-K teachers is the Child Development Associate (CDA). Available through the Council for Professional Recognition, the CDA is included by all states but one as part of their regulations for licensing childcare facilities. Experience and training are both included in eligibility requirements. Within the five years preceding the application, teachers must have worked with children for 480 hours. During that time they must also have had 120 clock hours of approved courses in child care education. In addition to passing the required courses, initial certification requires documentation of the applicant’s competence and observation of the teacher in the classroom setting. Following the observation, the applicant is interviewed. The initial certification is good for three years, renewals for five years. In addition to a current First Aid Certification, renewal requirements include 45 clock hours of training (4.5 continuing education units).
For more information on Sibling Group Holdings, visit www.newco4education.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) and FusionVax Sign a Memorandum of Understanding for the License of Advaxis’ ADXS-HPV in Asia
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- DoMark International, Inc. (DOMK) Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Looks Overseas for Potentially Lucrative Licensing Opportunities
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Aristocrat Group Corp. (ASCC) Brings Luxuria Brands to the Silver Screen
- The Guitammer Company Inc. (GTMM) Issues Shareholder Letter Recapping 2012 and Outlining 2013 Focus
- VentriPoint Diagnostics Ltd. (VPTDF) Receives Request for Clarification to 510 (k) Submission for Pulmonary Arterial Hypertension
- Viaspace, Inc. (VSPC) 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement